Table 2.
Tumor sizes, PSA levels, and final tumor stages stratified by Gleason score groups.
| n | Tumor size (mm) |
PSA level (ng/mL) |
Final tumor stage | |
|---|---|---|---|---|
| GS6 | 6 | 8.0 ± 2.4a | 5.9 ± 1.2 | cT2a (2) b |
| pT2c (4) | ||||
| GS7 (3 + 4) | 21 | 10.6 ± 4.2 | 6.5 ± 2.0 | cT2a (1), cT2b (3), cT2c (1) |
| pT2a (3), pT2c (9), pT3a (3), pT3b (1) | ||||
| GS7 (4 + 3) | 8 | 12.6 ± 5.0 | 9.2 ± 6.0 | cT2a (2), cT2b (1), cT2c (2), cT3a (1) |
| pT2a (1), pT2c (1) | ||||
| GS8–10 | 7 | 23.0 ± 17.6 | 19.0 ± 23.8 | cT2b (1), cT3a (2), cT3b (2) |
| pT3a (1), pT3b (1) |
aMean ± SD. bNumber of tumors.